Perspective Therapeutics, Inc. — Director's Dealing 2017

Jul 28, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2017-07-24

Reporting Person: Austin Mark John (Controller/Prin Fin&Acct Offic)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$0.58	2027-07-24	Common Stock (75000)		Direct

Footnotes

F1: 25% vested on 7/24/2017, and the remaining 75% will vest in 25% increments commencing on 6/30/2018 and on each anniversary thereafter, until fully vested.